GlassScriptPhysician profile
An H Tran
NPI 1790231801
$1,902.76
in general payments reported to CMS, 2019-2025
22 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $603 · 2024: $798 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,902.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $193.95 | 2023-2024 | Hawkone |
| Boston Scientific Corporation | $185.75 | 2024 | Embold Fibered |
| Alnylam Pharmaceuticals INC. | $162.37 | 2025 | Amvuttra |
| Abiomed | $145.47 | 2024 | Impella |
| Pfizer INC. | $143.10 | 2023-2025 | |
| Impulse Dynamics (USA) INC. | $132.72 | 2024 | Optimizer |
| Amgen INC. | $131.76 | 2023-2025 | Repatha, Repatha |
| Cvrx, INC. | $125.25 | 2023 | Barostim Neo System |
| Edwards Lifesciences Corporation | $121.22 | 2023 | |
| Merck Sharp & Dohme LLC | $87.01 | 2023-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $82.29 | 2024-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $81.87 | 2023-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $60.65 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.67 | 2023-2025 | Jardiance |
| Philips North America LLC | $35.61 | 2023-2024 | (5091) Amb Mon & Diag Und |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $33.29 | 2025 | Wegovy |
| Heartflow, INC. | $30.63 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.27 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.85 | 2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $18.02 | 2024 | |
| Scpharmaceuticals INC. | $15.19 | 2025 | |
| Atricure, INC. | $14.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw An Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.